Back to Search
Start Over
Evaluation of PAX2 and PAX8 expression in salivary gland neoplasms.
- Source :
-
Head and neck pathology [Head Neck Pathol] 2015 Mar; Vol. 9 (1), pp. 47-50. Date of Electronic Publication: 2014 Apr 26. - Publication Year :
- 2015
-
Abstract
- PAX2 and PAX8 are transcription factors involved in embryogenesis that have been utilized as immunohistochemical indicators of tumor origin. Specifically, PAX2 is a marker of neoplasms of renal and müllerian origin, while PAX8 is expressed by renal, müllerian, and thyroid tumors. While studies examining these transcription factors in a variety of tumors have been published, data regarding their expression in salivary gland neoplasms are limited. The goal of this study was to assess expression of PAX2 and PAX8 in a large cohort of salivary gland tumors. Utilizing tissue microarrays, samples of normal salivary glands (n = 68) and benign and malignant salivary gland neoplasms (n = 442) were evaluated for nuclear immunoreactivity with PAX2 and PAX8. No expression was observed with either marker in the normal salivary glands, and PAX8 was negative in all neoplasms. Focal expression of PAX2 was observed in one example each of oncocytoma and acinic cell carcinoma. These results indicate that evaluation of PAX2 and/or PAX8 expression would be valuable in differentiating primary salivary gland tumors from metastases known to express PAX2 and/or PAX8.
- Subjects :
- Humans
Immunohistochemistry
PAX2 Transcription Factor analysis
PAX8 Transcription Factor
Paired Box Transcription Factors analysis
Salivary Gland Neoplasms chemistry
Tissue Array Analysis
Biomarkers, Tumor analysis
PAX2 Transcription Factor biosynthesis
Paired Box Transcription Factors biosynthesis
Salivary Gland Neoplasms pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1936-0568
- Volume :
- 9
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Head and neck pathology
- Publication Type :
- Academic Journal
- Accession number :
- 24771139
- Full Text :
- https://doi.org/10.1007/s12105-014-0546-4